Revenue grew 38% to $11.6 million compared to $8.4 million in Q1 2024, and up 13% sequentially from $10.2 million in Q4 2024, driven by growth in Ohio. Q1 2025 operating cash flow reached $3.1 million compared to $0.1 million in the same period last year and $3.3 million for all of fiscal 2024. The closing of the previously announced acquisition of dispensaries in Athens and Jeffersonville, subsequent to quarter end, doubled... Read More